{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:17:40Z","timestamp":1782721060727,"version":"3.54.5"},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2025NSCQ-GPX1151"],"award-info":[{"award-number":["CSTB2025NSCQ-GPX1151"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010909","name":"Excellent Young Scientists Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82502225"],"award-info":[{"award-number":["82502225"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.isci.2025.114328","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:45:04Z","timestamp":1764780304000},"page":"114328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["United multi-omics and machine learning refine regulatory T cell-defined hepatocellular carcinoma subtypes"],"prefix":"10.1016","volume":"29","author":[{"given":"Wanli","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengdong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.114328_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2025.114328_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2025.114328_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg3750","article-title":"Comprehensive analysis of spatial architecture in primary liver cancer","volume":"7","author":"Wu","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.isci.2025.114328_bib4","first-page":"52","article-title":"Study of clinical outcome and prognosis in pediatric core binding factor-acute myeloid leukemia","volume":"40","author":"Wu","year":"2019","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.isci.2025.114328_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110943","article-title":"Vps33B controls Treg cell suppressive function through inhibiting lysosomal nutrient sensing complex-mediated mTORC1 activation","volume":"39","author":"Xiang","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2025.114328_bib6","first-page":"269","article-title":"Biomaterial-enhanced treg cell immunotherapy: A promising approach for transplant medicine and autoimmune disease treatment","volume":"37","author":"Mashayekhi","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.isci.2025.114328_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41746-019-0148-3","article-title":"Artificial intelligence and machine learning in clinical development: a translational perspective","volume":"2","author":"Shah","year":"2019","journal-title":"npj Digit. Med."},{"key":"10.1016\/j.isci.2025.114328_bib8","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s43018-024-00793-2","article-title":"A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics","volume":"5","author":"Hoang","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.isci.2025.114328_bib9","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2147\/JMDH.S410301","article-title":"Machine Learning and AI in Cancer Prognosis, Prediction, and Treatment Selection: A Critical Approach","volume":"16","author":"Zhang","year":"2023","journal-title":"J. Multidiscip. Healthc."},{"key":"10.1016\/j.isci.2025.114328_bib10","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/s41374-021-00653-y","article-title":"Establishing standardized immune phenotyping of metastatic melanoma by digital pathology","volume":"101","author":"Sobottka","year":"2021","journal-title":"Lab. Invest."},{"key":"10.1016\/j.isci.2025.114328_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100718","article-title":"Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies","volume":"53","author":"P\u00e9rez-Ruiz","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.isci.2025.114328_bib12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41392-023-01480-x","article-title":"Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2025.114328_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease","volume":"18","author":"Hasin","year":"2017","journal-title":"Genome Biol."},{"key":"10.1016\/j.isci.2025.114328_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.semcancer.2022.12.009","article-title":"Artificial intelligence-based multi-omics analysis fuels cancer precision medicine","volume":"88","author":"He","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.isci.2025.114328_bib15","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s10637-021-01126-1","article-title":"Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma","volume":"39","author":"Xiong","year":"2021","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.isci.2025.114328_bib16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3892\/mmr.2021.12122","article-title":"CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial-mesenchymal transition","volume":"24","author":"Yang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.isci.2025.114328_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1038069","article-title":"GTSE1, CDC20, PCNA, and MCM6 Synergistically Affect Regulations in Cell Cycle and Indicate Poor Prognosis in Liver Cancer","volume":"2019","author":"Zheng","year":"2019","journal-title":"Anal. Cell. Pathol."},{"key":"10.1016\/j.isci.2025.114328_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40164-022-00366-y","article-title":"CDCA8 induced by NF-YA promotes hepatocellular carcinoma progression by regulating the MEK\/ERK pathway","volume":"12","author":"Chen","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.isci.2025.114328_bib19","doi-asserted-by":"crossref","first-page":"11097","DOI":"10.1111\/jcmm.17032","article-title":"Cell division cycle associated 8: A novel diagnostic and prognostic biomarker for hepatocellular carcinoma","volume":"25","author":"Cui","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.isci.2025.114328_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12935-023-03185-1","article-title":"Transcription factors-related molecular subtypes and risk prognostic model: exploring the immunogenicity landscape and potential drug targets in hepatocellular carcinoma","volume":"24","author":"Wang","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.isci.2025.114328_bib21","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.7150\/ijbs.85656","article-title":"CENPA functions as a transcriptional regulator to promote hepatocellular carcinoma progression via cooperating with YY1","volume":"19","author":"Liao","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.isci.2025.114328_bib22","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/abbs\/gmy009","article-title":"Elevated G6PD expression contributes to migration and invasion of hepatocellular carcinoma cells by inducing epithelial-mesenchymal transition","volume":"50","author":"Lu","year":"2018","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.isci.2025.114328_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70801","article-title":"Bioinformatics Identification of Lactate-Associated Genes in Hepatocellular Carcinoma: G6PD's Role in Immune Modulation","volume":"14","author":"Qu","year":"2025","journal-title":"Cancer Med."},{"key":"10.1016\/j.isci.2025.114328_bib24","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.biopha.2019.01.028","article-title":"6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and metabolic reprogramming","volume":"111","author":"Chen","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.isci.2025.114328_bib25","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.neo.2016.10.002","article-title":"HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models","volume":"18","author":"Andreozzi","year":"2016","journal-title":"Neoplasia"},{"key":"10.1016\/j.isci.2025.114328_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108551","article-title":"NUDT16 enhances the resistance of cancer cells to DNA-damaging agents by regulating replication fork stability via reversing HMGA1 ADP-ribosylation","volume":"301","author":"Zhou","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2025.114328_bib27","doi-asserted-by":"crossref","first-page":"9909","DOI":"10.1038\/s41467-024-54400-0","article-title":"High mobility group A1 (HMGA1) promotes the tumorigenesis of colorectal cancer by increasing lipid synthesis","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.114328_bib28","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1080\/15384101.2021.1962624","article-title":"HN1 interacts with \u03b3-tubulin to regulate centrosomes in advanced prostate cancer cells","volume":"20","author":"Varisli","year":"2021","journal-title":"Cell Cycle"},{"key":"10.1016\/j.isci.2025.114328_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/kjm2.12156","article-title":"Increased expression of hematological and neurological expressed 1 (HN1) is associated with a poor prognosis of hepatocellular carcinoma and its knockdown inhibits cell growth and migration partly by down-regulation of c-Met","volume":"36","author":"Chen","year":"2020","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.isci.2025.114328_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.21037\/atm-21-6240","article-title":"Down regulated oncogene KIF2C inhibits growth, invasion, and metastasis of hepatocellular carcinoma through the Ras\/MAPK signaling pathway and epithelial-to-mesenchymal transition","volume":"10","author":"Mo","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.isci.2025.114328_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.livres.2021.06.001","article-title":"Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma","volume":"5","author":"Wang","year":"2021","journal-title":"Liver Res."},{"key":"10.1016\/j.isci.2025.114328_bib32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12967-024-06051-4","article-title":"G2M-checkpoint related immune barrier structure and signature for prognosis and immunotherapy response in hepatocellular carcinoma: insights from spatial transcriptome and machine learning","volume":"23","author":"Chen","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.isci.2025.114328_bib33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jhep.2013.02.030","article-title":"Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression","volume":"59","author":"Morita","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.isci.2025.114328_bib34","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/HEP.0000000000000962","article-title":"Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC","volume":"81","author":"Liu","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2025.114328_bib35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12967-018-1707-0","article-title":"Evaluation of the prognostic value of paraoxonase 1 in the recurrence and metastasis of hepatocellular carcinoma and establishment of a liver-specific predictive model of survival","volume":"16","author":"Yu","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.isci.2025.114328_bib36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bcp.2010.11.008","article-title":"Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on","volume":"81","author":"Costa","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.isci.2025.114328_bib37","article-title":"Identification of tumor stemness and immunity related prognostic factors and sensitive drugs in head and neck squamous cell carcinoma","volume":"14","author":"Ye","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.114328_bib38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41698-024-00510-3","article-title":"Development of a stemness-related prognostic index to provide therapeutic strategies for bladder cancer","volume":"8","author":"Fu","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.isci.2025.114328_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5803077","article-title":"Development of a Risk Predictive Model for Evaluating Immune Infiltration Status in Invasive Thyroid Carcinoma","volume":"2022","author":"Pang","year":"2022","journal-title":"Evid. Based. Complement. Alternat. Med."},{"key":"10.1016\/j.isci.2025.114328_bib40","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1042\/BST0390456","article-title":"Benefits of mTOR kinase targeting in oncology: pre-clinical evidence with AZD8055","volume":"39","author":"Marshall","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.isci.2025.114328_bib41","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41419-021-04371-7","article-title":"Akt inhibitor augments anti-proliferative efficacy of a dual mTORC1\/2 inhibitor by FOXO3a activation in p53 mutated hepatocarcinoma cells","volume":"12","author":"Patra","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2025.114328_bib42","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1007\/s10637-022-01268-w","article-title":"Comparison of dual mTORC1\/2 inhibitor AZD8055 and mTORC1 inhibitor rapamycin on the metabolism of breast cancer cells using proton nuclear magnetic resonance spectroscopy metabolomics","volume":"40","author":"Ni","year":"2022","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.isci.2025.114328_bib43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/0008-5472.CAN-09-1751","article-title":"AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity","volume":"70","author":"Chresta","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2025.114328_bib44","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.12659\/MSM.907514","article-title":"Targeting mTORC1\/2 Complexes Inhibit Tumorigenesis and Enhance Sensitivity to 5-Flourouracil (5-FU) in Hepatocellular Carcinoma: A Preclinical Study of mTORC1\/2-Targeted Therapy in Hepatocellular Carcinoma (HCC)","volume":"24","author":"Zhang","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.isci.2025.114328_bib45","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1158\/0008-5472.CAN-10-3968","article-title":"mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment","volume":"71","author":"Jiang","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2025.114328_bib46","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","article-title":"Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma","volume":"179","author":"Zhang","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.114328_bib47","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1158\/0008-5472.CAN-20-3175","article-title":"A TNFR2-hnRNPK Axis Promotes Primary Liver Cancer Development via Activation of YAP Signaling in Hepatic Progenitor Cells","volume":"81","author":"Meng","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2025.114328_bib48","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/1878-0261.12153","article-title":"Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma","volume":"12","author":"Grinchuk","year":"2018","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.isci.2025.114328_bib49","doi-asserted-by":"crossref","first-page":"10202","DOI":"10.1158\/0008-5472.CAN-10-2607","article-title":"A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients","volume":"70","author":"Roessler","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2025.114328_bib50","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1053\/j.gastro.2011.12.039","article-title":"Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival","volume":"142","author":"Roessler","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2025.114328_bib51","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1038\/onc.2014.438","article-title":"Integrative genomics identifies YY1AP1 as an oncogenic driver in EpCAM(+) AFP(+) hepatocellular carcinoma","volume":"34","author":"Zhao","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2025.114328_bib52","doi-asserted-by":"crossref","first-page":"8759","DOI":"10.1096\/fj.201802213RR","article-title":"Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth","volume":"33","author":"Wang","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.isci.2025.114328_bib53","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.7150\/ijbs.20836","article-title":"Transcriptome integration analysis in hepatocellular carcinoma reveals discordant intronic miRNA-host gene pairs in expression","volume":"13","author":"Sun","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.isci.2025.114328_bib54","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hep.27923","article-title":"Alternative splicing of the cell fate determinant Numb in hepatocellular carcinoma","volume":"62","author":"Lu","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2025.114328_bib55","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5604843","article-title":"Microarray Analysis For Expression Profiles of lncRNAs and circRNAs in Rat Liver after Brain-Dead Donor Liver Transplantation","volume":"2019","author":"Chen","year":"2019","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.isci.2025.114328_bib56","article-title":"Cleavage and Polyadenylation Specific Factor 1 Promotes Tumor Progression via Alternative Polyadenylation and Splicing in Hepatocellular Carcinoma","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.isci.2025.114328_bib57","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13046-021-01904-y","article-title":"Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma","volume":"40","author":"Wang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.isci.2025.114328_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101885","article-title":"Human constitutive androstane receptor represses liver cancer development and hepatoma cell proliferation by inhibiting erythropoietin signaling","volume":"298","author":"Li","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2025.114328_bib59","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/hep.31412","article-title":"Intratumoral \u03b3\u03b4 T-Cell Infiltrates, Chemokine (C-C Motif) Ligand 4\/Chemokine (C-C Motif) Ligand 5 Protein Expression and Survival in Patients With Hepatocellular Carcinoma","volume":"73","author":"Zhao","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2025.114328_bib60","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41556-023-01092-1","article-title":"Stiff matrix induces exosome secretion to promote tumour growth","volume":"25","author":"Wu","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.isci.2025.114328_bib61","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1007\/s13402-024-01019-4","article-title":"The survival prediction analysis and preliminary study of the biological function of YEATS2 in hepatocellular carcinoma","volume":"47","author":"Long","year":"2024","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.isci.2025.114328_bib62","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/gutjnl-2014-308483","article-title":"Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study","volume":"65","author":"Villa","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.isci.2025.114328_bib63","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ebiom.2018.12.031","article-title":"SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer","volume":"40","author":"Zubiete-Franco","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2025.114328_bib64","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/s41419-020-03180-8","article-title":"Proteoglycan-4 is correlated with longer survival in HCC patients and enhances sorafenib and regorafenib effectiveness via CD44 in vitro","volume":"11","author":"Dituri","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2025.114328_bib65","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3892\/ol.2022.13515","article-title":"Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma","volume":"24","author":"Critelli","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.isci.2025.114328_bib66","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1038\/s41467-020-18186-1","article-title":"The genomic landscape of Mongolian hepatocellular carcinoma","volume":"11","author":"Candia","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.114328_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302696","article-title":"Assessment of Gene Set Enrichment Analysis using curated RNA-seq-based benchmarks","volume":"19","author":"Candia","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.114328_bib68","article-title":"Macrophage-coated tumor cluster aggravates hepatoma invasion and immunotherapy resistance via generating local immune deprivation","volume":"5","author":"Ning","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2025.114328_bib69","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2025.114328_bib70","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab579","article-title":"Accurate and fast cell marker gene identification with COSG","volume":"23","author":"Dai","year":"2022","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.isci.2025.114328_bib71","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.isci.2025.114328_bib72","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1093\/bioinformatics\/btaa1018","article-title":"MOVICS: an R package for multi-omics integration and visualization in cancer subtyping","volume":"36","author":"Lu","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2025.114328_bib73","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.isci.2025.114328_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.687975","article-title":"IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures","volume":"12","author":"Zeng","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.114328_bib75","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data","volume":"22","author":"Maeser","year":"2021","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.isci.2025.114328_bib76","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.isci.2025.114328_bib77","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"key":"10.1016\/j.isci.2025.114328_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176278","article-title":"Integrative clustering of multi-level 'omic data based on non-negative matrix factorization algorithm","volume":"12","author":"Chalise","year":"2017","journal-title":"PLoS One"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225025891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225025891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T08:41:14Z","timestamp":1773996074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225025891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2589004225025891"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.114328","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"United multi-omics and machine learning refine regulatory T cell-defined hepatocellular carcinoma subtypes","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.114328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114328"}}